Suppression of atherogenesis in cholesterol-fed rabbits treated with nilvadipine, a new vasoselective calcium entry blocker
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 79 (2-3) , 147-155
- https://doi.org/10.1016/0021-9150(89)90119-6
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonistAtherosclerosis, 1987
- Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect.Journal of Clinical Investigation, 1985
- Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum. Possible role of calcium in atherogenesis.Journal of Clinical Investigation, 1980